Genetically engineered monoclonal antibodies armed with radionuclides.
Waldmann
T A
TA
Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000000981:diagnostic imaging / Q000378:metabolism / Q000532:radiotherapy; D001729:Bismuth / Q000627:therapeutic use; D015704:CD4 Antigens / Q000032:analysis / Q000096:biosynthesis / Q000145:classification / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000378:metabolism / Q000532:radiotherapy; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy; D015202:Protein Engineering; D016719:Radioimmunodetection; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D000922:Immunotoxins; D009363:Neoplasm Proteins; D011868:Radioisotopes; D015021:Yttrium Radioisotopes; D001729:Bismuth